Cargando…

Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression

BACKGROUND: The immune checkpoint inhibitor (ICI) anti-PD-L1 monoclonal antibody can inhibit the progress of hepatocellular carcinoma (HCC). Epithelial–mesenchymal transformation (EMT) can promote tumor migration and the formation of immune-suppression microenvironment, which affects the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Huijuan, Han, Jingxia, Lv, Ying, Zhao, Zihan, Zheng, Shaoting, Sun, Yu, Sun, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321013/ https://www.ncbi.nlm.nih.gov/pubmed/37408047 http://dx.doi.org/10.1186/s12951-023-01967-3

Ejemplares similares

Dissecting the roles and clinical potential of YY1 in the tumor microenvironment
por: Li, MengNa, et al.
Publicado: (2023)

Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency
por: Kong, Miao, et al.
Publicado: (2017)

Ruthenium-loaded mesoporous silica as tumor microenvironment-response nano-fenton reactors for precise cancer therapy
por: Sun, Dongdong, et al.
Publicado: (2021)

Mesoporous silica nanoparticles inflame tumors to overcome anti-PD-1 resistance through TLR4-NFκB axis
por: Sun, Mayu, et al.
Publicado: (2021)

Probing the Microenvironment in the Confined Pores of Mesoporous Silica Nanoparticles
por: Xue, Min, et al.
Publicado: (2014)

Homeostasis Imbalance of YY2 and YY1 Promotes Tumor Growth by Manipulating Ferroptosis
por: Li, Yanjun, et al.
Publicado: (2022)

Anti-Obesity Effects of Isorhamnetin and Isorhamnetin Conjugates
por: González-Arceo, Maitane, et al.
Publicado: (2022)

Hyaluronidase-Responsive Mesoporous Silica Nanoparticles with Dual-Imaging and Dual-Target Function
por: Wu, Zhi-Yuan, et al.
Publicado: (2019)

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
por: Jiang, Xianjie, et al.
Publicado: (2019)

Endothelial specific YY1 deletion restricts tumor angiogenesis and tumor growth
por: Liu, Huan, et al.
Publicado: (2020)

Preparation, Biosafety, and Cytotoxicity Studies of a Newly Tumor-Microenvironment-Responsive Biodegradable Mesoporous Silica Nanosystem Based on Multimodal and Synergistic Treatment
por: He, Zelai, et al.
Publicado: (2020)

A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets
por: Fu, Xinghao, et al.
Publicado: (2022)

Resveratrol-modified mesoporous silica nanoparticle for tumor-targeted therapy of gastric cancer
por: Lin, Mingzhen, et al.
Publicado: (2021)

The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice
por: Lee, Soyoung, et al.
Publicado: (2013)

Regulation of PD-L1 expression in the tumor microenvironment
por: Yi, Ming, et al.
Publicado: (2021)

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy
por: Zhao, Peiqi, et al.
Publicado: (2021)

Microbiota-derived imidazole propionate inhibits type 2 diabetic skin wound healing by targeting SPNS2-mediated S1P transport
por: Zheng, Shaoting, et al.
Publicado: (2023)

In Vivo Tumor Vasculature Targeted PET/NIRF Imaging with TRC105(Fab)-Conjugated, Dual-Labeled Mesoporous Silica Nanoparticles
por: Chen, Feng, et al.
Publicado: (2014)

Biosafety of Mesoporous Silica Nanoparticles
por: Rascol, Estelle, et al.
Publicado: (2018)

Mesoporous Silica Nanoparticles in Bioimaging
por: Yuan, Daohe, et al.
Publicado: (2020)

A Composite Hydrogel Containing Mesoporous Silica Nanoparticles Loaded With Artemisia argyi Extract for Improving Chronic Wound Healing
por: Xue, Leyi, et al.
Publicado: (2022)

CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma
por: Guo, Xiao-Jun, et al.
Publicado: (2021)

Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy
por: Chen, Feng, et al.
Publicado: (2014)

Multiple-Responsive Mesoporous Silica Nanoparticles for Highly Accurate Drugs Delivery to Tumor Cells
por: Jin, Ronghua, et al.
Publicado: (2018)

Nanometer-scale distribution of PD-1 in the melanoma tumor microenvironment
por: Comerci, Colin J, et al.
Publicado: (2023)

Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles
por: Zhu, Chun-Ling, et al.
Publicado: (2014)

Mesoporous Silica Nanoparticles for Dual-Mode Chemo-Sonodynamic Therapy by Low-Energy Ultrasound
por: Wang, Jingjing, et al.
Publicado: (2018)

Isorhamnetin inhibits progression of ovarian cancer by targeting ESR1
por: Wang, Manman, et al.
Publicado: (2022)

Selecting suitable chemotherapies for PD-1/PD-L1 blockade to optimize the tumor immune microenvironment
por: Koyama, Shohei, et al.
Publicado: (2018)

VEGF(121)-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System
por: Goel, Shreya, et al.
Publicado: (2014)

Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery
por: Naz, Safia, et al.
Publicado: (2019)

Cetyltrimethylammonium chloride-loaded mesoporous silica nanoparticles as a mitochondrion-targeting agent for tumor therapy
por: Tang, Menghuan, et al.
Publicado: (2020)

Ultrasound-Responsive Biomimetic Superhydrophobic Drug-Loaded Mesoporous Silica Nanoparticles for Treating Prostate Tumor
por: Jin, Qiaofeng, et al.
Publicado: (2023)

Formation pathways of mesoporous silica nanoparticles with dodecagonal tiling
por: Sun, Yao, et al.
Publicado: (2017)

Retroposition and evolution of the DNA-binding motifs of YY1, YY2 and REX1
por: Kim, Jeong Do, et al.
Publicado: (2007)

Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radiation therapy and anti-PD-1/PD-L1
por: Mukherjee, Debayan, et al.
Publicado: (2023)

Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye
por: Guo, Huichen, et al.
Publicado: (2011)

Tumor microenvironment enhanced NIR II fluorescence imaging for tumor precise surgery navigation via tetrasulfide mesoporous silica-coated Nd-based rare-earth nanocrystals
por: Li, Jiaqi, et al.
Publicado: (2022)

Phospholipid-Coated Mesoporous Silica Nanoparticles Acting as Lubricating Drug Nanocarriers
por: Sun, Tao, et al.
Publicado: (2018)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d57fr9cpkn6hdim56vqm6kgsp8